Ranibizumab reimbursement and treatment patterns for neovascular age-related macular degeneration in Taiwan – Results from the 12-month, observational RENOWNED study

Journal

Journal of the Formosan Medical Association

Date Issued

2022

Author(s)

Chen S.-N.

Lai C.-C.

Choi H.-Y.

Kuo C.-N.

Tsai C.-Y.

Wang H.-I.

DOI

10.1016/j.jfma.2022.02.005

URI

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85126110656&doi=10.1016%2fj.jfma.2022.02.005&partnerID=40&md5=8d16211d0013c78aa1cde1de4fbc005a

https://scholars.lib.ntu.edu.tw/handle/123456789/615229

Publisher

Elsevier B.V.

Type

journal article